123 results
POS AM
SRNEQ
Sorrento Therapeutics, Inc.
18 Jul 23
Prospectus update (post-effective amendment)
5:23pm
, a sustained desensitization occurs, resulting in reduction of noxious chronic pain symptoms that can last for months. RTX has the potential to be a multi … occurs, resulting in reduction of noxious chronic pain symptoms that can last for months. RTX has the potential to be a multi-indication franchise asset
POS AM
SRNEQ
Sorrento Therapeutics, Inc.
21 Jun 23
Prospectus update (post-effective amendment)
5:24pm
, a sustained desensitization occurs, resulting in reduction of noxious chronic pain symptoms that can last for months. RTX has the potential to be a multi … transient receptor potential vanilloid-1 agonist. When injected peripherally, a sustained desensitization occurs, resulting in reduction of noxious chronic
POS AM
SRNEQ
Sorrento Therapeutics, Inc.
12 May 23
Prospectus update (post-effective amendment)
5:28pm
in reduction of noxious chronic pain symptoms that can last for months. RTX has the potential to be a multi-indication franchise asset and is nearing … injected peripherally, a sustained desensitization occurs, resulting in reduction of noxious chronic pain symptoms that can last for months. RTX has
8-K
EX-99.1
bkx7jl7
29 Sep 22
Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Pay Off of Remaining Balance of its Senior Secured Notes
9:00am
425
oo4qy4r ee7xt69
14 Jun 22
Business combination disclosure
2:51pm
8-K
EX-99.1
n7m4johib16jsohkizv
14 Jun 22
Entry into a Material Definitive Agreement
2:32pm
8-K
EX-99.1
b6dm9uz5fb fhk
3 Jun 22
Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Repurchase of $41.4 Million of its Senior Secured Notes
9:00am
8-K
EX-99.1
6u22q9drw0w jez35
28 Apr 22
Departure of Directors or Certain Officers
9:00am
8-K
EX-99.1
fupwdg1 hs
4 Apr 22
Results of Operations and Financial Condition
9:01am
8-K
EX-99.1
66cin 9byg
18 Mar 22
Regulation FD Disclosure
4:35pm
425
EX-99.2
i4yybxo qd5mu7
18 Mar 22
Business combination disclosure
9:03am
425
EX-99.1
4tvuk1fakq62kppam2
18 Mar 22
Business combination disclosure
9:03am
8-K
EX-99.2
rlhg6zqkm
18 Mar 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-99.1
k0g2id00pjfkbpb7fhx
18 Mar 22
Entry into a Material Definitive Agreement
9:01am